← Latest papers
🦠 microbiology

Potent broad-spectrum antiviral activity of the marine natural product Plitidepsin

This study demonstrates that plitidepsin, a marine-derived anticancer drug targeting the host factor eEF1A, exhibits potent, broad-spectrum antiviral activity against a wide range of RNA and DNA viruses by disrupting multiple stages of the viral life cycle, thereby highlighting its therapeutic potential and reduced risk of resistance development.

Original authors: Campos, D., Galan Jurado, P. E., Valdes Torres, P., Zegarra, D., Tunon Lorenzo, I., Gonzalez Castillo, F., Castillo Mewa, J., Hurtado, J., Moreno, P., Moratorio, G., Rivas, C., Gonzalez Santamaria, J.

Published 2026-02-25
📖 4 min read☕ Coffee break read

Original authors: Campos, D., Galan Jurado, P. E., Valdes Torres, P., Zegarra, D., Tunon Lorenzo, I., Gonzalez Castillo, F., Castillo Mewa, J., Hurtado, J., Moreno, P., Moratorio, G., Rivas, C., Gonzalez Santamaria, J.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

🌊 The Treasure of the Sea: The Emergence of 'Plitidepsin'

We are all aware that viruses (such as those causing colds, flu, or chickenpox) invade our body's cells and cause illness. Typically, we use drugs that attack the virus itself, but because viruses mutate rapidly, these drugs often lose effectiveness.

This research team came up with the idea: "What if, instead of directly catching the virus, we tightly lock the 'house' (our body's cells) where the virus can survive?"

The protagonist they discovered is 'Plitidepsin,' a natural substance derived from the sea. Originally used as an anticancer drug, it was found to have a remarkable effect in blocking viruses.

🏭 Locking the Factory Commander 'eEF1A': The Core Mechanism

To understand how this drug works, let's use a 'factory' analogy:

  1. The Virus's Plan: Once a virus penetrates our cells, it leaves behind a 'fake blueprint.' It then forcibly turns on our cell factory's machinery to mass-produce only viruses.
  2. The Factory's Key Commander: Inside our cell factory, there is a very important commander called 'eEF1A.' This commander instructs, "Assemble these parts to create products (proteins)!" The virus tricks this commander into making its own parts (viral proteins).
  3. Plitidepsin's Operation: Plitidepsin temporarily ties up this commander (eEF1A).
    • Even if the virus commands, "Make this!", the commander cannot move, so viral parts are not produced.
    • However, the parts needed for our cells to survive normally are still produced, so the cells do not die. (This is the 'selective' effect.)

🦠 Which Enemies Were Defeated? (Broad-Spectrum Effect)

The research team tested how effective this drug is against various enemies.

  • Primary Enemies (Mosquito-borne viruses): Tropical viruses transmitted by mosquitoes, such as Mayaro (MAYV) and Chikungunya (CHIKV), were reduced by more than 1 million times (6 logs) even with extremely small amounts measured in nanometers. It is like stopping a massive flood with a tiny drop of water.
  • Other Enemies: It also blocked Influenza (flu), Herpes (chickenpox/shingles), and even the DNA virus Cytomegalovirus (HCMV).
  • Conclusion: This drug is not a 'specialist' that catches only specific viruses, but a 'universal shield' that blocks viruses regardless of their type.

⏰ The Golden Time for Treatment: Effective Even Up to 8 Hours!

The most surprising point is that it works no matter when it is taken.

  • Usually, antiviral drugs work best if taken early in the infection.
  • However, Plitidepsin could prevent viral replication even when administered 8 hours after infection.
  • This is like extinguishing a fire with a fire hydrant even 8 hours after the blaze started, meaning it significantly extends the 'golden time' for treatment, allowing patients who arrive at the hospital late to still be treated.

🛡️ Why Is This Discovery Important?

  1. Less Problem of Drug Resistance: Viruses easily adapt and mutate in response to drugs. However, Plitidepsin attacks our body's cells (the factory commander), not the virus itself. Since viruses cannot change our body's cells, it is very difficult for them to develop resistance to the drug.
  2. Safety: It has already been used in humans as an anticancer drug, so there is some existing data on side effects.
  3. Preparation for Future Pandemics: Developing a new drug every time a new virus emerges takes time. However, since this drug is an existing 'universal weapon,' it can serve as a card for immediate response when a new virus appears.

📝 Summary

This paper proves the fact that "a drug from the sea (Plitidepsin) locks our body's factory commander, preventing various viruses from replicating."

It is like finding a master key that blocks all locks. We look forward to this drug being used to treat more viral infectious diseases through future clinical trials.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →